White Blood Cell Count Measured Prior to Cancer Development Is Associated with Future Risk of Venous Thromboembolism – The Tromsø Study

BACKGROUND: Elevated white blood cell (WBC) count is associated with risk of venous thromboembolism (VTE) in cancer patients initiating chemotherapy. It is not known whether the risk of VTE by WBC count in cancer patients is causal or merely a consequence of the malignant disease. To address this qu...

Descripción completa

Detalles Bibliográficos
Autores principales: Blix, Kristine, Jensvoll, Hilde, Brækkan, Sigrid K., Hansen, John-Bjarne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762748/
https://www.ncbi.nlm.nih.gov/pubmed/24023876
http://dx.doi.org/10.1371/journal.pone.0073447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762748/
https://www.ncbi.nlm.nih.gov/pubmed/24023876
http://dx.doi.org/10.1371/journal.pone.0073447

Ejemplares similares